Natixis Advisors LLC Lowers Position in The Clorox Company $CLX

Natixis Advisors LLC decreased its position in The Clorox Company (NYSE:CLX) by 29.5% during the 4th quarter, Holdings Channel reports. The fund owned 55,955 shares of the company’s stock after selling 23,394 shares during the quarter. Natixis Advisors LLC’s holdings in Clorox were worth $5,642,000 as of its most recent filing with the Securities & Exchange Commission.

Several other hedge funds and other institutional investors have also made changes to their positions in the company. Center for Financial Planning Inc. purchased a new stake in Clorox during the third quarter worth about $25,000. Vermillion & White Wealth Management Group LLC purchased a new stake in Clorox during the third quarter worth about $25,000. Darwin Wealth Management LLC purchased a new stake in Clorox during the second quarter worth about $29,000. Vision Financial Markets LLC boosted its holdings in Clorox by 166.7% during the fourth quarter. Vision Financial Markets LLC now owns 320 shares of the company’s stock worth $32,000 after buying an additional 200 shares in the last quarter. Finally, Ameriflex Group Inc. lifted its holdings in shares of Clorox by 1,436.8% in the third quarter. Ameriflex Group Inc. now owns 292 shares of the company’s stock valued at $36,000 after purchasing an additional 273 shares in the last quarter. Hedge funds and other institutional investors own 78.53% of the company’s stock.

Clorox Price Performance

Clorox stock opened at $95.11 on Tuesday. The firm has a market capitalization of $11.50 billion, a P/E ratio of 15.44, a PEG ratio of 0.49 and a beta of 0.56. The firm has a fifty day moving average of $96.81 and a 200-day moving average of $105.31. The company has a quick ratio of 0.65, a current ratio of 0.84 and a debt-to-equity ratio of 27.03. The Clorox Company has a 52-week low of $84.70 and a 52-week high of $132.03.

Clorox (NYSE:CLX) last announced its earnings results on Thursday, April 30th. The company reported $1.64 earnings per share for the quarter, beating the consensus estimate of $1.55 by $0.09. The business had revenue of $1.67 billion during the quarter, compared to the consensus estimate of $1.67 billion. Clorox had a net margin of 11.18% and a return on equity of 443.64%. The business’s quarterly revenue was up .1% compared to the same quarter last year. During the same period in the prior year, the firm earned $1.45 earnings per share. Clorox has set its FY 2026 guidance at 5.450-5.650 EPS. As a group, analysts predict that The Clorox Company will post 5.61 EPS for the current year.

Insider Transactions at Clorox

In other Clorox news, Director Pierre R. Breber acquired 5,000 shares of the company’s stock in a transaction on Tuesday, May 5th. The shares were bought at an average cost of $85.82 per share, for a total transaction of $429,100.00. Following the acquisition, the director directly owned 18,000 shares of the company’s stock, valued at $1,544,760. This trade represents a 38.46% increase in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. 0.63% of the stock is owned by corporate insiders.

Analysts Set New Price Targets

A number of equities analysts have recently weighed in on CLX shares. Wells Fargo & Company cut their price objective on shares of Clorox from $100.00 to $95.00 and set an “equal weight” rating for the company in a research report on Monday, May 18th. Barclays dropped their price target on shares of Clorox from $102.00 to $85.00 and set an “underweight” rating for the company in a research report on Friday, May 1st. UBS Group dropped their price target on shares of Clorox from $110.00 to $96.00 and set a “neutral” rating for the company in a research report on Friday, May 1st. Jefferies Financial Group dropped their price target on shares of Clorox from $139.00 to $125.00 and set a “buy” rating for the company in a research report on Monday, May 4th. Finally, Morgan Stanley dropped their price target on shares of Clorox from $110.00 to $97.00 and set an “equal weight” rating for the company in a research report on Friday, May 1st. One investment analyst has rated the stock with a Buy rating, eleven have given a Hold rating and five have given a Sell rating to the company. According to data from MarketBeat.com, the stock presently has an average rating of “Reduce” and an average price target of $103.40.

About Clorox

The Clorox Company is a leading manufacturer and marketer of consumer and professional products designed to help people care for their homes and live healthy, sustainable lives. Its portfolio spans cleaning and household products, food and beverages, water filtration systems and cat litter, serving both retail and institutional customers. The company’s flagship bleach and disinfecting products are well known in the United States and many international markets, where they help prevent the spread of germs in homes, hospitals, schools and businesses.

Clorox’s diverse brand lineup includes liquid bleach and surface cleaners, eco-friendly cleaning tools, food preservation and preparation items, charcoal grills and briquettes, specialty foods and beverages, pet care products and personal care lines.